APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal OTC Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gastrointestinal OTC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchGastrointestinal OTC Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal OTC Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Gastrointestinal OTC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal OTC Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal OTC Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gastrointestinal OTC Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastrointestinal OTC Drugs include Boehringer Ingelheim, Perrigo, Procter & Gamble, Purdue Pharma, Reckitt Benckiser, Bayer, GlaxoSmithKline, Pfizer and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gastrointestinal OTC Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastrointestinal OTC Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastrointestinal OTC Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gastrointestinal OTC Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Gastrointestinal OTC Drugs Segment by Company

Boehringer Ingelheim

Perrigo

Procter & Gamble

Purdue Pharma

Reckitt Benckiser

Bayer

GlaxoSmithKline

Pfizer

Johnson & Johnson

Nestle

Sanofi

Teva Pharmaceutical

Abbott

Gastrointestinal OTC Drugs Segment by Type

Anti-Emetics

Laxatives

Anti-Flatulents

Anti-Diarrheals

PPIs

H2-Antaginists

Other

Gastrointestinal OTC Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Gastrointestinal OTC Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal OTC Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal OTC Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal OTC Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gastrointestinal OTC Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastrointestinal OTC Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gastrointestinal OTC Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gastrointestinal OTC Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gastrointestinal OTC Drugs Industry Trends Table 2. Gastrointestinal OTC Drugs Industry Drivers Table 3. Gastrointestinal OTC Drugs Industry Opportunities and Challenges Table 4. Gastrointestinal OTC Drugs Industry Restraints Table 5. Global Gastrointestinal OTC Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gastrointestinal OTC Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers Table 9. Global Gastrointestinal OTC Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Gastrointestinal OTC Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gastrointestinal OTC Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gastrointestinal OTC Drugs Manufacturers, Product Type & Application Table 13. Global Gastrointestinal OTC Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gastrointestinal OTC Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Anti-Emetics Table 17. Major Manufacturers of Laxatives Table 18. Major Manufacturers of Anti-Flatulents Table 19. Major Manufacturers of Anti-Diarrheals Table 20. Major Manufacturers of PPIs Table 21. Major Manufacturers of H2-Antaginists Table 22. Major Manufacturers of Other Table 23. Global Gastrointestinal OTC Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Gastrointestinal OTC Drugs Sales by Type (2021-2026) & (K Units) Table 25. Global Gastrointestinal OTC Drugs Sales by Type (2027-2032) & (K Units) Table 26. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2021-2026) Table 27. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2027-2032) Table 28. Global Gastrointestinal OTC Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 29. Global Gastrointestinal OTC Drugs Revenue by Type (2021-2026) & (K Units) Table 30. Global Gastrointestinal OTC Drugs Revenue by Type (2027-2032) & (K Units) Table 31. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2021-2026) Table 32. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Retail Pharmacies Table 34. Major Manufacturers of Online Pharmacies Table 35. Major Manufacturers of Hospital Pharmacies Table 36. Global Gastrointestinal OTC Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Gastrointestinal OTC Drugs Sales by Application (2021-2026) & (K Units) Table 38. Global Gastrointestinal OTC Drugs Sales by Application (2027-2032) & (K Units) Table 39. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2021-2026) Table 40. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2027-2032) Table 41. Global Gastrointestinal OTC Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Gastrointestinal OTC Drugs Revenue by Application (2021-2026) & (K Units) Table 43. Global Gastrointestinal OTC Drugs Revenue by Application (2027-2032) & (K Units) Table 44. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2021-2026) Table 45. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2027-2032) Table 46. Global Gastrointestinal OTC Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Gastrointestinal OTC Drugs Sales by Region (2021-2026) & (K Units) Table 48. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2021-2026) Table 49. Global Gastrointestinal OTC Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Gastrointestinal OTC Drugs Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Gastrointestinal OTC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 53. North America Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 54. Europe Gastrointestinal OTC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 56. Europe Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Gastrointestinal OTC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Gastrointestinal OTC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 63. Global Gastrointestinal OTC Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Gastrointestinal OTC Drugs Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Gastrointestinal OTC Drugs Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2021-2026) Table 67. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2027-2032) Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. Perrigo Company Information Table 74. Perrigo Business Overview Table 75. Perrigo Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Perrigo Gastrointestinal OTC Drugs Product Portfolio Table 77. Perrigo Recent Development Table 78. Procter & Gamble Company Information Table 79. Procter & Gamble Business Overview Table 80. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio Table 82. Procter & Gamble Recent Development Table 83. Purdue Pharma Company Information Table 84. Purdue Pharma Business Overview Table 85. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio Table 87. Purdue Pharma Recent Development Table 88. Reckitt Benckiser Company Information Table 89. Reckitt Benckiser Business Overview Table 90. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio Table 92. Reckitt Benckiser Recent Development Table 93. Bayer Company Information Table 94. Bayer Business Overview Table 95. Bayer Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Bayer Gastrointestinal OTC Drugs Product Portfolio Table 97. Bayer Recent Development Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio Table 102. GlaxoSmithKline Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Pfizer Gastrointestinal OTC Drugs Product Portfolio Table 107. Pfizer Recent Development Table 108. Johnson & Johnson Company Information Table 109. Johnson & Johnson Business Overview Table 110. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio Table 112. Johnson & Johnson Recent Development Table 113. Nestle Company Information Table 114. Nestle Business Overview Table 115. Nestle Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Nestle Gastrointestinal OTC Drugs Product Portfolio Table 117. Nestle Recent Development Table 118. Sanofi Company Information Table 119. Sanofi Business Overview Table 120. Sanofi Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Sanofi Gastrointestinal OTC Drugs Product Portfolio Table 122. Sanofi Recent Development Table 123. Teva Pharmaceutical Company Information Table 124. Teva Pharmaceutical Business Overview Table 125. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio Table 127. Teva Pharmaceutical Recent Development Table 128. Abbott Company Information Table 129. Abbott Business Overview Table 130. Abbott Gastrointestinal OTC Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Abbott Gastrointestinal OTC Drugs Product Portfolio Table 132. Abbott Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Gastrointestinal OTC Drugs Distributors List Table 136. Gastrointestinal OTC Drugs Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Gastrointestinal OTC Drugs Product Image Figure 2. Global Gastrointestinal OTC Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal OTC Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastrointestinal OTC Drugs Sales (2021-2032) & (K Units) Figure 5. Global Gastrointestinal OTC Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Gastrointestinal OTC Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Anti-Emetics Image Figure 9. Laxatives Image Figure 10. Anti-Flatulents Image Figure 11. Anti-Diarrheals Image Figure 12. PPIs Image Figure 13. H2-Antaginists Image Figure 14. Other Image Figure 15. Global Gastrointestinal OTC Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Gastrointestinal OTC Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2021-2032) Figure 18. Global Gastrointestinal OTC Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Gastrointestinal OTC Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2021-2032) Figure 21. Retail Pharmacies Image Figure 22. Online Pharmacies Image Figure 23. Hospital Pharmacies Image Figure 24. Global Gastrointestinal OTC Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Gastrointestinal OTC Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2021-2032) Figure 27. Global Gastrointestinal OTC Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Gastrointestinal OTC Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2021-2032) Figure 30. North America Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2032) Figure 32. U.S. Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2032) Figure 37. Germany Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2032) Figure 44. China Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2032) Figure 52. Brazil Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Gastrointestinal OTC Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Gastrointestinal OTC Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Gastrointestinal OTC Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Figure 63. North America Gastrointestinal OTC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Europe Gastrointestinal OTC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Gastrointestinal OTC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Gastrointestinal OTC Drugs Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Gastrointestinal OTC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Gastrointestinal OTC Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Gastrointestinal OTC Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Emetics
  • Laxatives
  • Anti-Flatulents
  • Anti-Diarrheals
  • PPIs
  • H2-Antaginists
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Boehringer Ingelheim
  • Perrigo
  • Procter & Gamble
  • Purdue Pharma
  • Reckitt Benckiser
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Johnson & Johnson
  • Nestle
  • Sanofi
  • Teva Pharmaceutical
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gastrointestinal OTC Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gastrointestinal OTC Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gastrointestinal OTC Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gastrointestinal OTC Drugs Market Dynamics
  1. 2.1 Gastrointestinal OTC Drugs Industry Trends
  2. 2.2 Gastrointestinal OTC Drugs Industry Drivers
  3. 2.3 Gastrointestinal OTC Drugs Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal OTC Drugs Industry Restraints
3 Gastrointestinal OTC Drugs Market by Manufacturers
  1. 3.1 Global Gastrointestinal OTC Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gastrointestinal OTC Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gastrointestinal OTC Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gastrointestinal OTC Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastrointestinal OTC Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gastrointestinal OTC Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Gastrointestinal OTC Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastrointestinal OTC Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastrointestinal OTC Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastrointestinal OTC Drugs Tier 1, Tier 2, and Tier 3
4 Gastrointestinal OTC Drugs Market by Type
  1. 4.1 Gastrointestinal OTC Drugs Type Introduction
  2. 4.1.1 Anti-Emetics
  3. 4.1.2 Laxatives
  4. 4.1.3 Anti-Flatulents
  5. 4.1.4 Anti-Diarrheals
  6. 4.1.5 PPIs
  7. 4.1.6 H2-Antaginists
  8. 4.1.7 Other
  9. 4.2 Global Gastrointestinal OTC Drugs Sales by Type
  10. 4.2.1 Global Gastrointestinal OTC Drugs Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Gastrointestinal OTC Drugs Sales by Type (2021-2032)
  12. 4.2.3 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2021-2032)
  13. 4.3 Global Gastrointestinal OTC Drugs Revenue by Type
  14. 4.3.1 Global Gastrointestinal OTC Drugs Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Gastrointestinal OTC Drugs Revenue by Type (2021-2032)
  16. 4.3.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2021-2032)
5 Gastrointestinal OTC Drugs Market by Application
  1. 5.1 Gastrointestinal OTC Drugs Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Gastrointestinal OTC Drugs Sales by Application
  6. 5.2.1 Global Gastrointestinal OTC Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastrointestinal OTC Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Gastrointestinal OTC Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Gastrointestinal OTC Drugs Revenue by Application
  10. 5.3.1 Global Gastrointestinal OTC Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gastrointestinal OTC Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2021-2032)
6 Global Gastrointestinal OTC Drugs Sales by Region
  1. 6.1 Global Gastrointestinal OTC Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gastrointestinal OTC Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Gastrointestinal OTC Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Gastrointestinal OTC Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gastrointestinal OTC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gastrointestinal OTC Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gastrointestinal OTC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gastrointestinal OTC Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gastrointestinal OTC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gastrointestinal OTC Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gastrointestinal OTC Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gastrointestinal OTC Drugs Revenue by Region
  1. 7.1 Global Gastrointestinal OTC Drugs Revenue by Region
  2. 7.1.1 Global Gastrointestinal OTC Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gastrointestinal OTC Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Gastrointestinal OTC Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gastrointestinal OTC Drugs Revenue (2021-2032)
  8. 7.2.2 North America Gastrointestinal OTC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gastrointestinal OTC Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Gastrointestinal OTC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gastrointestinal OTC Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gastrointestinal OTC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gastrointestinal OTC Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gastrointestinal OTC Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Perrigo
  8. 8.2.1 Perrigo Company Information
  9. 8.2.2 Perrigo Business Overview
  10. 8.2.3 Perrigo Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Perrigo Gastrointestinal OTC Drugs Product Portfolio
  12. 8.2.5 Perrigo Recent Developments
  13. 8.3 Procter & Gamble
  14. 8.3.1 Procter & Gamble Company Information
  15. 8.3.2 Procter & Gamble Business Overview
  16. 8.3.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio
  18. 8.3.5 Procter & Gamble Recent Developments
  19. 8.4 Purdue Pharma
  20. 8.4.1 Purdue Pharma Company Information
  21. 8.4.2 Purdue Pharma Business Overview
  22. 8.4.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio
  24. 8.4.5 Purdue Pharma Recent Developments
  25. 8.5 Reckitt Benckiser
  26. 8.5.1 Reckitt Benckiser Company Information
  27. 8.5.2 Reckitt Benckiser Business Overview
  28. 8.5.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio
  30. 8.5.5 Reckitt Benckiser Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Gastrointestinal OTC Drugs Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Gastrointestinal OTC Drugs Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
  55. 8.10 Nestle
  56. 8.10.1 Nestle Company Information
  57. 8.10.2 Nestle Business Overview
  58. 8.10.3 Nestle Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nestle Gastrointestinal OTC Drugs Product Portfolio
  60. 8.10.5 Nestle Recent Developments
  61. 8.11 Sanofi
  62. 8.11.1 Sanofi Company Information
  63. 8.11.2 Sanofi Business Overview
  64. 8.11.3 Sanofi Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi Gastrointestinal OTC Drugs Product Portfolio
  66. 8.11.5 Sanofi Recent Developments
  67. 8.12 Teva Pharmaceutical
  68. 8.12.1 Teva Pharmaceutical Company Information
  69. 8.12.2 Teva Pharmaceutical Business Overview
  70. 8.12.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio
  72. 8.12.5 Teva Pharmaceutical Recent Developments
  73. 8.13 Abbott
  74. 8.13.1 Abbott Company Information
  75. 8.13.2 Abbott Business Overview
  76. 8.13.3 Abbott Gastrointestinal OTC Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Abbott Gastrointestinal OTC Drugs Product Portfolio
  78. 8.13.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gastrointestinal OTC Drugs Value Chain Analysis
  2. 9.1.1 Gastrointestinal OTC Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gastrointestinal OTC Drugs Production Mode & Process
  6. 9.2 Gastrointestinal OTC Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gastrointestinal OTC Drugs Distributors
  9. 9.2.3 Gastrointestinal OTC Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst